Maintaining high levels of syngeneic bone marrow engraftment while omitting cyclophosphamide in busulfan-containing conditioning regimens [7]

Blood

Volumn 92, Issue 4, 1998, Pages 1462-1463

  Westerhof, G R ^a   Ploemacher, R E ^a   Down, J D ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL KILLING; CHIMERA; CHRONIC MYELOID LEUKEMIA; CONDITIONING; DOSE RESPONSE; ERYTHROID CELL; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032529673     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1462     Document Type: Letter

References (6)